Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Department of Labor Reports a Decline in Worker Death Investigations

Workplace fatalities requiring OSHA investigation fell 11% from 2023 to 2024.
Read More →
November 11, 2024

CMS to Reduce Medicare Physician Fee

The physician fee schedule will be reduced by 2.93%, while other changes are in store for primary care, telehealth, and more.
Read More →
November 11, 2024

Vermont Seeks Stakeholder Input on Medical Fee Schedule

Written comments from stakeholders who use the fee schedule will be accepted until December 15th.
Read More →
November 11, 2024

California to Hold Webinar on 2024 Geo Study

The December 4th webinar will cover regional differences in the California workers’ comp system.
Read More →
November 11, 2024

Department of Justice Reaches $21.5 Million Settlement Over Inflated AWP for Compound Ingredients

According to the DOJ, Medisca Inc. purchased resveratrol at $0.37 a gram, sold it for under $2.00 a gram, but reported an AWP of $777 per gram.
Read More →
November 11, 2024

Psychedelic Study Shows Improvements in Anxiety without Hallucinations

When injected into the hippocampus, the compound DOI reduced anxiety in mice without causing hallucinations.
Read More →
November 4, 2024

Texas Seeks Input On 2025 Medical Quality Review Audit Plan

Comments will be accepted until 5:00 PM PST on November 22, 2024, and the Medical Advisor may adjust the plan based on feedback received.
Read More →
November 4, 2024

Pennsylvania Publishes Prescription Drug Trends Report

This report reviews drug payments between 2012 and 2022, reviewing usage and cost, generics, opioids, and topicals.
Read More →
November 4, 2024

Nevada to Hold Four Workers’ Comp Training Webinars

The webinars will cover basic orientation, the C-4 process and using the coverage verification system, the D-35 form, and medical billing.
Read More →
November 4, 2024
1 … 33 34 35 36 37 … 41

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

FDA Approves Elyxyb Oral Solution for Migraines

Elyxyb (celecoxib) is an NSAID for the acute treatment of migraine with or without aura.
Read More

Live Better, Heal Better: Employee Wellness in Workers' Comp

How comorbidities, fatigue, and mental health impact claims management.
Read More

Texas Reminds Providers Certain Exams Must Be Done in Person

Maximum medical improvement (MME) and impairment rating (IR) evaluations cannot be done remotely.
Read More

Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.
Read More

State of the States

A roundup of regulatory activity around the country
Read More

IQVIA Reports on Healthcare Shifts in the COVID-19 Era

A new study explores patients’ use of health services, the impact on medicine use, research activity, and more.
Read More
1 … 33 34 35 36 37 … 48
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle